...
首页> 外文期刊>Drug development and industrial pharmacy >Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets.
【24h】

Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets.

机译:可溶性和不溶性环糊精聚合物对羟丙基甲基纤维素片剂中药物释放的影响。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: The influence of beta-cyclodextrin (beta-CD) polymers on drug release from hydroxypropyl methylcellulose (HPMC) matrices has not been reported in the literature. AIM: The influence of monomeric beta-CD and both soluble and insoluble beta-CD polymers on drug release from tablets containing either 30% or 50% hydroxypropyl methylcellulose has been studied using diflunisal (DF) as model drug. METHOD: The DF-beta-CD inclusion complex (1:1 M) was prepared by coevaporation and characterised using X-ray diffraction, differential thermal analysis, and IR spectroscopy. The dissolution assays were performed according to the USP paddle method. RESULTS: The incorporation of beta-CD in the complexed form increases drug release from hydroxypropyl methylcellulose tablets in comparison with the physical mixture because of the better solubilization of the drug. The soluble polymer promotes drug release to a higher extent than the physical mixture with monomeric beta-CD, but the insoluble polymer, which is itself a hydrogel, gives rise to the most retarded release profile, probably by retention of the drug in its structure. The formulations containing physical mixtures with either beta-CD or the soluble polymer present an optimum adjustment to zero-order release kinetics, and the inclusion complex followed non-Fickian diffusion according to the Korsmeyer-Peppas model. CONCLUSION: The release profile of DF from a HPMC matrix can be modulated in different ways by the use of either monomeric or polymeric beta-CD.
机译:背景:β-环糊精(β-CD)聚合物对药物从羟丙基甲基纤维素(HPMC)基质中释放的影响尚未见报道。目的:使用双氟尼沙尔(DF)作为模型药物,研究了单体β-CD以及可溶性和不溶性β-CD聚合物对含有30%或50%羟丙基甲基纤维素的片剂的药物释放的影响。方法:通过共蒸发制备DF-β-CD包合物(1:1 M),并使用X射线衍射,差热分析和IR光谱进行表征。根据USP桨法进行溶出测定。结果:与β-CD的复合形式掺入相比于物理混合物,增加了从羟丙基甲基纤维素片中的药物释放,因为该药物具有更好的溶解性。可溶性聚合物比与单体β-CD的物理混合物促进药物释放的程度更高,但本身是水凝胶的不溶性聚合物可能会由于药物保留在其结构中而产生最延迟的释放特性。根据Korsmeyer-Peppas模型,包含与β-CD或可溶性聚合物的物理混合物的制剂可对零级释放动力学进行最佳调节,并且包合物遵循非菲克扩散。结论:通过使用单体或聚合β-CD,可以不同方式调节DF从HPMC基质中的释放曲线。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号